Clinical trial

Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension

NCT00139698

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention olmesartan alone or in combination with hydrochlorothiazide Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-09-01

PhasePHASE3

Conditions

Essential Hypertensionverified · MONDO: essential hypertension

Interventions

olmesartan alone or in combination with hydrochlorothiazideDRUG

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

TaipeiTaiwan2 SingaporeSingapore2 BangkokThailand2 Kaohsiung CityTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00139698 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.